Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy.
Trials
; 20(1): 721, 2019 12 13.
Article
in En
| MEDLINE
| ID: mdl-31836017
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2019
Document type:
Article
Affiliation country:
Netherlands
Country of publication:
United kingdom